Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.

<h4>Background</h4>COVID-19, a highly infectious respiratory disease, has been associated with a range of cardiovascular complications. One of the most commonly reported cardiovascular issues in COVID-19 patients is the development of arrhythmias. Among all types of arrhythmias, atrial f...

Full description

Bibliographic Details
Main Authors: Muhammad Shakir, Syed Muhammad Hassan, Ursala Adil, Syed Muhammad Aqeel Abidi, Syed Ahsan Ali
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291829&type=printable
_version_ 1797349390088667136
author Muhammad Shakir
Syed Muhammad Hassan
Ursala Adil
Syed Muhammad Aqeel Abidi
Syed Ahsan Ali
author_facet Muhammad Shakir
Syed Muhammad Hassan
Ursala Adil
Syed Muhammad Aqeel Abidi
Syed Ahsan Ali
author_sort Muhammad Shakir
collection DOAJ
description <h4>Background</h4>COVID-19, a highly infectious respiratory disease, has been associated with a range of cardiovascular complications. One of the most commonly reported cardiovascular issues in COVID-19 patients is the development of arrhythmias. Among all types of arrhythmias, atrial fibrillation is the most frequently observed. Atrial fibrillation is characterized by an irregular and often rapid heartbeat, and it can be a serious and potentially life-threatening condition.<h4>Objective</h4>To investigate the incidence and association of new onset atrial fibrillation in COVID-19 hospitalized patients and its impact on survival.<h4>Method</h4>A retrospective cross-sectional study that encompassed all patients, both positive and negative for COVID-19, who were consecutively admitted to the Aga Khan University Hospital in Karachi, a tertiary care facility, from June 2021 to December 2021.<h4>Results</h4>A total of 1,313 patients who met the inclusion criteria of our study were enrolled as participants. These patients were then stratified into two groups based on COVID-19 status: the study group (COVID-19 positive) comprised 626 (47.7%) patients and the control group (COVID-19 negative) consisted of 687 (52.3%) patients. The incidence of new-onset atrial fibrillation was 85 (13.6%) in COVID-19 positive compared to 43 (5.2%) in COVID-19 negative group. The study found a strong association between COVID-19 and new-onset atrial fibrillation in both univariate (unadjusted odd ratio 2.35 [95% CI, 1.60-3.45], p-value < 0.01) and a multiple-adjusted regression analysis (adjusted odd ratio 3.86 [95% CI, 2.31-6.44], p-value < 0.01).<h4>Conclusion</h4>These findings highlight the importance of vigilant monitoring of cardiovascular complications in COVID-19 patients, especially those with pre-existing conditions that predispose them to the development of atrial fibrillation. The study underscores the need for prompt recognition and management of new onset atrial fibrillation in COVID-19 patients, as this may mitigate the risk of adverse outcomes and improve overall prognosis.
first_indexed 2024-03-08T12:29:44Z
format Article
id doaj.art-ef2d2729890744fe90b288fb3ea5cc8f
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-08T12:29:44Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ef2d2729890744fe90b288fb3ea5cc8f2024-01-22T05:31:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01191e029182910.1371/journal.pone.0291829Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.Muhammad ShakirSyed Muhammad HassanUrsala AdilSyed Muhammad Aqeel AbidiSyed Ahsan Ali<h4>Background</h4>COVID-19, a highly infectious respiratory disease, has been associated with a range of cardiovascular complications. One of the most commonly reported cardiovascular issues in COVID-19 patients is the development of arrhythmias. Among all types of arrhythmias, atrial fibrillation is the most frequently observed. Atrial fibrillation is characterized by an irregular and often rapid heartbeat, and it can be a serious and potentially life-threatening condition.<h4>Objective</h4>To investigate the incidence and association of new onset atrial fibrillation in COVID-19 hospitalized patients and its impact on survival.<h4>Method</h4>A retrospective cross-sectional study that encompassed all patients, both positive and negative for COVID-19, who were consecutively admitted to the Aga Khan University Hospital in Karachi, a tertiary care facility, from June 2021 to December 2021.<h4>Results</h4>A total of 1,313 patients who met the inclusion criteria of our study were enrolled as participants. These patients were then stratified into two groups based on COVID-19 status: the study group (COVID-19 positive) comprised 626 (47.7%) patients and the control group (COVID-19 negative) consisted of 687 (52.3%) patients. The incidence of new-onset atrial fibrillation was 85 (13.6%) in COVID-19 positive compared to 43 (5.2%) in COVID-19 negative group. The study found a strong association between COVID-19 and new-onset atrial fibrillation in both univariate (unadjusted odd ratio 2.35 [95% CI, 1.60-3.45], p-value < 0.01) and a multiple-adjusted regression analysis (adjusted odd ratio 3.86 [95% CI, 2.31-6.44], p-value < 0.01).<h4>Conclusion</h4>These findings highlight the importance of vigilant monitoring of cardiovascular complications in COVID-19 patients, especially those with pre-existing conditions that predispose them to the development of atrial fibrillation. The study underscores the need for prompt recognition and management of new onset atrial fibrillation in COVID-19 patients, as this may mitigate the risk of adverse outcomes and improve overall prognosis.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291829&type=printable
spellingShingle Muhammad Shakir
Syed Muhammad Hassan
Ursala Adil
Syed Muhammad Aqeel Abidi
Syed Ahsan Ali
Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
PLoS ONE
title Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
title_full Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
title_fullStr Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
title_full_unstemmed Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
title_short Unveiling the silent threat of new onset atrial fibrillation in covid-19 hospitalized patients: A retrospective cohort study.
title_sort unveiling the silent threat of new onset atrial fibrillation in covid 19 hospitalized patients a retrospective cohort study
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0291829&type=printable
work_keys_str_mv AT muhammadshakir unveilingthesilentthreatofnewonsetatrialfibrillationincovid19hospitalizedpatientsaretrospectivecohortstudy
AT syedmuhammadhassan unveilingthesilentthreatofnewonsetatrialfibrillationincovid19hospitalizedpatientsaretrospectivecohortstudy
AT ursalaadil unveilingthesilentthreatofnewonsetatrialfibrillationincovid19hospitalizedpatientsaretrospectivecohortstudy
AT syedmuhammadaqeelabidi unveilingthesilentthreatofnewonsetatrialfibrillationincovid19hospitalizedpatientsaretrospectivecohortstudy
AT syedahsanali unveilingthesilentthreatofnewonsetatrialfibrillationincovid19hospitalizedpatientsaretrospectivecohortstudy